Strategy

Non-Alc in the GLP-1 Era

Weight loss drugs have changed a lot more than waistlines. As prescriptions for Ozempic, Wegovy, and Mounjaro skyrocket (more than 5 million Americans are already taking them, with projections of 30 million by 2030), their ripple effects are moving far

Read Article